Current
Neuro-Oncology


Volume 19 Number 1
31 January 2017


Home > Publications > Current Neuro-Oncology > Volume 19, Year 2017 > Number 1, 31 January






Radhakrishnan V, Perumal J, Sundersingh S, Sagar T.
Lomustine induced acute pulmonary toxicity in a pediatric medulloblastoma survivor.
South Asian J Cancer. 2017 Jan-Mar;6(1):38-39
. doi: 10.4103/2278-330X.202570. PMID: 28413799. Letter to the Editor. ˍ




Sasikumar A, Joy A, Pillai MR, Nanabala R, Anees K M, Jayaprakash PG, Madhavan J, Nair S.
Diagnostic Value of 68Ga PSMA-11 PET/CT Imaging of Brain Tumors-Preliminary Analysis.
Clin Nucl Med. 2017 Jan;42(1):e41-e48. doi: 10.1097/RLU.0000000000001451.
PMID: 27846000. Interventional study. ˍ




Noiphithak R, Veerasarn K.
Clinical predictors for survival and treatment outcome of high-grade glioma in Prasat Neurological Institute.
Asian J Neurosurg. 2017 Jan 1, 2017;12(1):28-33
. doi: 10.4103/1793-5482.148791? PMID: 28413528. Observational study. ˍ




Mistry AM, Dewan MC, White-Dzuro GA, Brinson PR, Weaver KD, Thompson RC, Ihrie RA, Chambless LB.
Decreased survival in glioblastomas is specific to contact with the ventricular-subventricular zone, not subgranular zone or corpus callosum.
J Neurooncol. 2017 Jan 10, 2017;132(2):341-349. doi: 10.1007/s11060-017-2374-3. PMID: 28074322. Observational study. ˍ




Pinel B, Duchesne M, Godet J, Milin S, Berger A, Wager M, Karayan-Tapon L.
Mesenchymal subtype of glioblastomas with high DNA-PKcs expression is associated with better response to radiotherapy and temozolomide.
J Neurooncol. 2017 Jan 10, 2017;132(2):287-294. doi: 10.1007/s11060-016-2367-7. PMID: 28070830. Laboratory investigation. ˍ




Ion-Mărgineanu A, Van Cauter S, Sima DM, Maes F, Sunaert S, Himmelreich U, Van Huffel S.
Classifying Glioblastoma Multiforme Follow-Up Progressive vs. Responsive Forms Using Multi-Parametric MRI Features.
Front Neurosci. 2017 Jan 11;10:615. doi: 10.3389/fnins.2016.00615. PMID: 28123355. Observational study. ˍ




Lucas JT Jr, Serrano N, Kim H, Li X, Snyder SE, Hwang S, Li Y, Hua CH, Broniscer A, Merchant TE, Shulkin BL.
11C-Methionine positron emission tomography delineates non-contrast enhancing tumor regions at high risk for recurrence in pediatric high-grade glioma.
J Neurooncol. 2017 Jan 11, 2017;132(1):163-170. doi: 10.1007/s11060-016-2354-z. PMID: 28078638. Observational study. ˍ




Alvarado AG, Thiagarajan PS, Mulkearns-Hubert EE, Silver DJ, Hale JS, Alban TJ, Turaga SM, Jarrar A, Reizes O, Longworth MS, Vogelbaum MA, Lathia JD.
Glioblastoma Cancer Stem Cells Evade Innate Immune Suppression of Self-Renewal through Reduced TLR4 Expression.
Cell Stem Cell. 2017 Jan 12, 2017;20(4):450-461.e4
. doi: 10.1016/j.stem.2016.12.001. PMID: 28089910. Laboratory investigation. ˍ




Pai T, Epari S, Desai S, Wadile A, Gupta T, Goda JS, Moiyadi A, Shetty P, Kane S, Jalali R.
Histological spectrum of oligodendroglial tumors: Only a subset shows 1p/19q codeletion.
Neurol India. 2017 Jan 12, 2017;65(1):113-120. doi: 10.4103/0028-3886.198195. PMID: 28084254. Observational study. ˍ




Burman P, van Beek AP, Biller BM, Camacho-Hübner C, Mattsson AF.
Radiotherapy, Especially at Young Age, Increases the Risk for De Novo Brain Tumors in Patients Treated for Pituitary/Sellar Lesions.
J Clin Endocrinol Metab. 2017 Jan
13, 2017;102(3):1051-1058. doi: 10.1210/jc.2016-3402. PMID: 28359095. Observational study. ˍ




Tinkle CL, Orr BA, Lucas JT Jr, Klimo P, Patay Z, Baker SJ, Broniscer A, Qaddoumi I.
Rapid and fulminant leptomeningeal spread following radiotherapy in diffuse intrinsic pontine glioma.
Pediatr Blood Cancer. 2017 Jan 13, 2017;64(8):10.1002/pbc.26416. doi: 10.1002/pbc.26416. PMID: 28084680. Case report. ˍ




Baugh J, Bartels U, Leach J, Jones B, Chaney B, Warren KE, Kirkendall J, Doughman R, Hawkins C, Miles L, Fuller C, Hassall T, Bouffet E, Lane A, Hargrave D, Grill J, Hoffman LM, Jones C, Towbin A, Savage SA, Monje M, Li XN, Ziegler DS, van Zanten SV, Kramm CM, van Vuurden DG, Fouladi M.
The international diffuse intrinsic pontine glioma registry: an infrastructure to accelerate collaborative research for an orphan disease.
J Neurooncol. 2017 Jan 16, 2017;132(2):323-331. doi: 10.1007/s11060-017-2372-5. PMID: 28093680. Observational study. ˍ




Bačun T, Kibel A, Degmečić D, Pavić R.
From erectile dysfunction to brain subependymoma: a Case report.
Acta Clin Croat. [2017 Jan 17], 2020;59(1):173-176. doi: 10.20471/acc.2020.59.01.22. PMID: 32724290. Case report. ˍ




Chandra P, Purandare N, Shah S, Agrawal A, Rangarajan V.
"Drop" Metastases from an Operated Case of Intracranial Anaplastic Ependymoma Identified on Fluoro-2-deoxyglucose Positron Emission Tomography/Computed Tomography.
Indian J Nucl Med. 2017 Jan 17, 2017;32(1):68-70. doi: 10.4103/0972-3919.198492. PMID: 28242994. Case report. ˍ




Sidaway P.
Immunotherapy: Glioblastoma regression obtained with CAR T cells.
Nat Rev Clin Oncol. 2017 Jan 17, 2017;14(3):138. doi: 10.1038/nrclinonc.2017.2. PMID: 28094259. Comment. ˍ
Refers to: Brown CE, et al., Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy.
N Engl J Med. 2016 Dec 29;375(26):2561-9. doi: 10.1056/NEJMoa1610497. PMID: 28029927. Case report and Interventional study. ˍ




Hata N, Yoshimoto K, Hatae R, Kuga D, Akagi Y, Sangatsuda Y, Suzuki SO, Shono T, Mizoguchi M, Iihara K.
Add-on bevacizumab can prevent early clinical deterioration and prolong survival in newly diagnosed partially resected glioblastoma patients with a poor performance status.
Onco Targets Ther. 2017 Jan 18;10:429-437
. doi: 10.2147/OTT.S125587. PMID: 28176936. Observational study. ˍ




Tseng JH, Chen CY, Chen PC, Hsiao SH, Fan CC, Liang YC, Chen CP.
Valproic acid inhibits glioblastoma multiforme cell growth via paraoxonase 2 expression.
Oncotarget. 2017 Jan 18, 2017;8(9):14666-14679. doi: 10.18632/oncotarget.14716. PMID: 28108734. Laboratory investigation. ˍ




Kossatz S, Carney B, Schweitzer M, Carlucci G, Miloushev VZ, Maachani UB, Rajappa P, Keshari KR, Pisapia D, Weber WA, Souweidane MM, Reiner T.
Biomarker-Based PET Imaging of Diffuse Intrinsic Pontine Glioma in Mouse Models.
Cancer Res. 2017 Jan 20, 2017;77(8):2112-2123
. doi: 10.1158/0008-5472.CAN-16-2850. PMID: 28108511. Laboratory investigation. ˍ




Veldhuijzen van Zanten SE, Baugh J, Chaney B, De Jongh D, Sanchez Aliaga E, Barkhof F, Noltes J, De Wolf R, Van Dijk J, Cannarozzo A, Damen-Korbijn CM, Lieverst JA, Colditz N, Hoffmann M, Warmuth-Metz M, Bison B, Jones DT, Sturm D, Gielen GH, Jones C, Hulleman E, Calmon R, Castel D, Varlet P, Giraud G, Slavc I, Van Gool S, Jacobs S, Jadrijevic-Cvrlje F, Sumerauer D, Nysom K, Pentikainen V, Kivivuori SM, Leblond P, Entz-Werle N, von Bueren AO, Kattamis A, Hargrave DR, Hauser P, Garami M, Thorarinsdottir HK, Pears J, Gandola L, Rutkauskiene G, Janssens GO, Torsvik IK, Perek-Polnik M, Gil-da-Costa MJ, Zheludkova O, Shats L, Deak L, Kitanovski L, Cruz O, Morales La Madrid A, Holm S, Gerber N, Kebudi R, Grundy R, Lopez-Aguilar E, Zapata-Tarres M, Emmerik J, Hayden T, Bailey S, Biassoni V, Massimino M, Grill J, Vandertop WP, Kaspers GJ, Fouladi M, Kramm CM, van Vuurden DG; members of the SIOPE DIPG Network.
Development of the SIOPE DIPG network, registry and imaging repository: a collaborative effort to optimize research into a rare and lethal disease.
J Neurooncol. 2017 Jan 21, 2017;132(2):255-266. doi: 10.1007/s11060-016-2363-y. PMID: 28110411. Observational study. ˍ




Wang P, Wan WW, Xiong SL, Feng H, Wu N.
Cancer stem-like cells can be induced through dedifferentiation under hypoxic conditions in glioma, hepatoma and lung cancer.
Cell Death Discov. 2017 Jan 23;3:16105
. doi: 10.1038/cddiscovery.2016.105. PMID: 28179999. Laboratory investigation. ˍ




Xi G, Li YD, Grahovac G, Rajaram V, Wadhwani N, Pundy T, Mania-Farnell B, James CD, Tomita T.
Targeting CD133 improves chemotherapeutic efficacy of recurrent pediatric pilocytic astrocytoma following prolonged chemotherapy.
Mol Cancer. 2017 Jan 31;16(1):21
. doi: 10.1186/s12943-017-0593-z. PMID: 28137267. Observational study. ˍ